Fig. 5.

Leptin and adiponectin in acute phase as predictors for in-hospital death. Values shown are Odds ratios (OR) with 95% confidence intervals for leptin and adiponectin concentrations in the acute phase and risk for in-hospital death for all (filled triangle, n = 128), for women (filled square, n = 80), and for men (open square, n = 48). Leptin and adiponectin were categorized into quartiles based on the cohort and sex-specific distribution amongst cases at baseline. The ORs represent the increased risk associated with the higher three quartiles (Q2_4) versus the reference (OR 1.00, the lowest Q1). Footnote: Cut-offs Q1 versus Q2_4 in absolute values for the different cohorts stratified for sex are for leptin (ng/mL): MONICA; 5.7 (only men): VIP; men 2.6, women 6.5: MSP 8.0 and NSMC 1.7 (only women in both) and for adiponectin (mg/mL): MONICA; 5.2 (only men): VIP; men 4.1, women 6.2: MSP 7.4 and NSMC 6.8 (only women in both). Abbreviations: MONICA, the Northern Sweden MONItoring Of trends and Determinants in CArdivascular Disease; VIP, Västerbotten Intervention Program; MSP, the Mammary Screening Program; NSMC, Northern Sweden Maternity Cohort